Edward N Wilson

Edward N Wilson

Stanford University

H-index: 12

North America-United States

About Edward N Wilson

Edward N Wilson, With an exceptional h-index of 12 and a recent h-index of 12 (since 2020), a distinguished researcher at Stanford University, specializes in the field of Neurodegenerative disease, Alzheimer Disease, Parkinson's Disease, Neuroinflammation, Biomarkers.

His recent articles reflect a diverse array of research interests and contributions to the field:

Post‐translational modifications linked to preclinical Alzheimer's disease–related pathological and cognitive changes

Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease.

Nanolithium, a New Treatment Approach to Alzheimer’s Disease: A Review of Existing Evidence and Clinical Perspectives

Plasma pTau181 reveals a pathological signature that predicts cognitive outcomes in Lewy body disease

CSF proteomic profiling with amyloid/tau positivity identifies distinctive sex-different alteration of multiple proteins involved in Alzheimer disease

Associations of APOE4 and Alzheimer’s disease biomarkers with cortical reinstatement and episodic memory in clinically unimpaired older adults

PET imaging of TREM1 identifies CNS-infiltrating myeloid cells in a mouse model of multiple sclerosis

Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer’s disease

Edward N Wilson Information

University

Position

___

Citations(all)

575

Citations(since 2020)

518

Cited By

218

hIndex(all)

12

hIndex(since 2020)

12

i10Index(all)

14

i10Index(since 2020)

14

Email

University Profile Page

Google Scholar

Edward N Wilson Skills & Research Interests

Neurodegenerative disease

Alzheimer Disease

Parkinson's Disease

Neuroinflammation

Biomarkers

Top articles of Edward N Wilson

Post‐translational modifications linked to preclinical Alzheimer's disease–related pathological and cognitive changes

Alzheimer's & Dementia

2024/3

Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease.

2024/2/16

Nanolithium, a New Treatment Approach to Alzheimer’s Disease: A Review of Existing Evidence and Clinical Perspectives

2024/1/24

Plasma pTau181 reveals a pathological signature that predicts cognitive outcomes in Lewy body disease

medRxiv

2024

CSF proteomic profiling with amyloid/tau positivity identifies distinctive sex-different alteration of multiple proteins involved in Alzheimer disease

medRxiv

2024

Associations of APOE4 and Alzheimer’s disease biomarkers with cortical reinstatement and episodic memory in clinically unimpaired older adults

Alzheimer's & Dementia

2023/12

PET imaging of TREM1 identifies CNS-infiltrating myeloid cells in a mouse model of multiple sclerosis

Science translational medicine

2023/6/28

Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer’s disease

Research square

2023/6/9

Using plasma ptau181 in Lewy Body Disease spectrum for the identification of Alzheimer’s disease co‐pathology

Alzheimer's & Dementia

2023/12

CSF Biomarkers of Amyloid and Tau Pathologies in Participants Enrolled in the Stanford Alzheimer’s Disease Research Center

Alzheimer's & Dementia

2022/12

Hippocampal CA1 volume is associated with higher p‐tau and diminished memory performance in normal older adults

Alzheimer's & Dementia

2022/12

Multi‐modal biomarkers improve prediction of memory function in cognitively unimpaired older adults

Alzheimer's & Dementia

2022/12

Administration of Selective α2‐Adrenergic Receptor Agonist Dexmedetomidine During Spine Surgery is Associated with Reduced Postoperative Increase in Plasma p‐Tau181

Alzheimer's & Dementia

2022/12

Edward N Wilson
Edward N Wilson

H-Index: 8

Diagnostic and Prognostic Performance of the Modified Lumipulse pTau 181 Assay in Plasma for Alzheimer’s Disease

Alzheimer's & Dementia

2022/12

Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease

Alzheimer's Research & Therapy

2022/11/12

α‐Synuclein seed amplification in CSF and brain from patients with different brain distributions of pathological α‐synuclein in the context of co‐pathology and non‐LBD diagnoses

Annals of neurology

2022/10

Edward N Wilson
Edward N Wilson

H-Index: 8

Limited proteolysis–mass spectrometry reveals aging-associated changes in cerebrospinal fluid protein abundances and structures

Nature Aging

2022/5

Edward N Wilson
Edward N Wilson

H-Index: 8

Plasma biomarkers of tau and neurodegeneration during major cardiac and noncardiac surgery

JAMA neurology

2021/11/1

Igor Feinstein
Igor Feinstein

H-Index: 3

Edward N Wilson
Edward N Wilson

H-Index: 8

TAM-ping down amyloid in Alzheimer’s disease

Nature immunology

2021/5

Edward N Wilson
Edward N Wilson

H-Index: 8

See List of Professors in Edward N Wilson University(Stanford University)

Co-Authors

academic-engine